TRML logo

Tourmaline Bio, Inc. (TRML) Cash from operations

annual CFO:

-$77.26M-$49.18M(-175.14%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TRML annual cash flow from operations is -$77.26 million, with the most recent change of -$49.18 million (-175.14%) on December 31, 2024.
  • During the last 3 years, TRML annual CFO has fallen by -$37.27 million (-93.22%).
  • TRML annual CFO is now -1096.39% below its all-time high of -$6.46 million, reached on December 31, 2022.

Performance

TRML Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

quarterly CFO:

-$20.26M+$1.42M(+6.53%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRML quarterly cash flow from operations is -$20.26 million, with the most recent change of +$1.42 million (+6.53%) on June 30, 2025.
  • Over the past year, TRML quarterly CFO has dropped by -$2.26 million (-12.53%).
  • TRML quarterly CFO is now -150.00% below its all-time high of $40.53 million, reached on December 1, 2022.

Performance

TRML quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

TTM CFO:

-$86.28M-$2.26M(-2.69%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRML TTM cash flow from operations is -$86.28 million, with the most recent change of -$2.26 million (-2.69%) on June 30, 2025.
  • Over the past year, TRML TTM CFO has dropped by -$38.60 million (-80.95%).
  • TRML TTM CFO is now -495.74% below its all-time high of $21.80 million, reached on September 30, 2023.

Performance

TRML TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TRML Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-175.1%-12.5%-81.0%
3 y3 years-93.2%-17.3%-61.2%
5 y5 years-337.5%-480.1%-536.2%

TRML Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1096.4%at low-150.0%+13.6%-495.7%at low
5 y5-year-1096.4%at low-150.0%+13.6%-495.7%at low
alltimeall time-1096.4%at low-150.0%+13.6%-495.7%at low

TRML Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$20.26M(-6.5%)
-$86.28M(+2.7%)
Mar 2025
-
-$21.68M(+3.8%)
-$84.02M(+8.7%)
Dec 2024
-$77.26M(+175.1%)
-$20.89M(-10.9%)
-$77.26M(+17.6%)
Sep 2024
-
-$23.44M(+30.2%)
-$65.73M(+37.9%)
Jun 2024
-
-$18.01M(+20.7%)
-$47.68M(+21.6%)
Mar 2024
-
-$14.92M(+59.6%)
-$39.21M(+39.6%)
Dec 2023
-$28.08M(+334.8%)
-$9.35M(+73.3%)
-$28.08M(-228.8%)
Sep 2023
-
-$5.40M(-43.4%)
$21.80M(+58.3%)
Jun 2023
-
-$9.54M(+151.7%)
$13.77M(+128.3%)
Mar 2023
-
-$3.79M(-109.4%)
$6.03M(-193.4%)
Dec 2022
-$6.46M
-
-
Dec 2022
-
$40.53M(-401.8%)
-$6.46M(-88.6%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$13.43M(-22.3%)
-$56.82M(+6.2%)
Jun 2022
-
-$17.28M(+6.1%)
-$53.52M(+13.3%)
Mar 2022
-
-$16.28M(+65.6%)
-$47.22M(+18.1%)
Dec 2021
-$39.99M(+108.1%)
-$9.83M(-3.0%)
-$39.99M(+11.7%)
Sep 2021
-
-$10.13M(-7.8%)
-$35.81M(+17.4%)
Jun 2021
-
-$10.98M(+21.4%)
-$30.50M(+32.5%)
Mar 2021
-
-$9.05M(+60.1%)
-$23.02M(+19.8%)
Dec 2020
-$19.21M(+8.8%)
-$5.65M(+17.1%)
-$19.21M(+41.7%)
Sep 2020
-
-$4.83M(+38.2%)
-$13.56M(+55.2%)
Jun 2020
-
-$3.49M(-33.4%)
-$8.74M(+66.6%)
Mar 2020
-
-$5.24M
-$5.24M
Dec 2019
-$17.66M
-
-

FAQ

  • What is Tourmaline Bio, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. annual CFO year-on-year change?
  • What is Tourmaline Bio, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. quarterly CFO year-on-year change?
  • What is Tourmaline Bio, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. TTM CFO year-on-year change?

What is Tourmaline Bio, Inc. annual cash flow from operations?

The current annual CFO of TRML is -$77.26M

What is the all time high annual CFO for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high annual cash flow from operations is -$6.46M

What is Tourmaline Bio, Inc. annual CFO year-on-year change?

Over the past year, TRML annual cash flow from operations has changed by -$49.18M (-175.14%)

What is Tourmaline Bio, Inc. quarterly cash flow from operations?

The current quarterly CFO of TRML is -$20.26M

What is the all time high quarterly CFO for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high quarterly cash flow from operations is $40.53M

What is Tourmaline Bio, Inc. quarterly CFO year-on-year change?

Over the past year, TRML quarterly cash flow from operations has changed by -$2.26M (-12.53%)

What is Tourmaline Bio, Inc. TTM cash flow from operations?

The current TTM CFO of TRML is -$86.28M

What is the all time high TTM CFO for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high TTM cash flow from operations is $21.80M

What is Tourmaline Bio, Inc. TTM CFO year-on-year change?

Over the past year, TRML TTM cash flow from operations has changed by -$38.60M (-80.95%)
On this page